Alex Toker: Tumor Microenvironment Takes Center Stage at FASEB 2026
Alex Toker/LinkedIn

Alex Toker: Tumor Microenvironment Takes Center Stage at FASEB 2026

Alex Toker, Professor of Pathology at Beth Israel Deaconess Medical Center, shared a post on LinkedIn:

“Session Spotlight: Tumor Microenvironment

The TME is no longer a bystander, it’s a co-conspirator. How do stromal, immune, and malignant cell interactions shape tumor progression and therapy resistance? John Blenis, Mara Sherman, Sandra McAllister and Daniel Bondeson will dissect the signaling crosstalk that defines the tumor ecosystem.

Submit an abstract and join the conversation!

Co-located with the FASEB meeting Protein Phosphorylation in Health and Disease — two conferences, one venue, one unmissable week for the signaling community.

FASEB Cell Signaling in Cancer | July 13–15, 2026 | The Galt House, Louisville, KY
Conference registration open now.”

Alex Toker: Tumor Microenvironment Takes Center Stage at FASEB 2026

See other articles on OncoDaily.